ThetaPal ThetaPal

Manufacturing / Pharmaceutical Preparations

ZEVRA THERAPEUTICS, INC.

ZVRA

$11.40

+$0.42 (+3.78%)

Price as of Oct 9, 2026 20:31 UTC

690 M

Market Cap (Small Cap)

23%

IV Rank

93.2%

Implied Volatility

Nov 03

Next Earnings

Technical Signals as of Oct 7
Bearish
2 of 7

Trend

  • Above 20-day average $11.17
  • Above 50-day average $11.47
  • Above 200-day average $10.67 · +3.9%
  • Moving averages stacked Not aligned

Momentum

  • Golden cross (50/200) —
  • Momentum cross (20/50) Down · 9d ago

Volume

  • Below-average volume 1.0x avg

Price & Trend

Daily candles with EMA 20, SMA 50. Drag to zoom.

Options Activity & Greeks

Implied volatility, flow, and dealer positioning from the options market.

Put/Call Ratio

1.22

Bearish skew

Implied Volatility

93.2%

1% percentile

IV vs Realized

Options rich

30d HV 34.7%

Options Heat Map

Delta-risk grid for ZVRA options across strikes and expirations. Hover any cell for full Greeks.

Loading option chain data...

Insider Trades

3 buys 14 sells
Date Insider Title Type Shares Value Since Trade
Aug 14, 2026 Thompson Rahsaan Sell 42,666 $474,774 -1.1%
Aug 10, 2026 Watton Corey Michael Exercise 12,300 $61,131 +121.3%
Aug 10, 2026 Watton Corey Michael Sell 12,300 $138,377 -2.2%
Aug 10, 2026 Watton Corey Michael Exercise 12,300 $0 -4.2%
Jun 22, 2026 Thompson Rahsaan Sell 34,557 $438,304 -13.3%
Jun 21, 2026 Thompson Rahsaan Exercise 66,667 $0 -13.0%
Jun 21, 2026 Thompson Rahsaan Exercise 66,667 $0 -13.0%
Jun 04, 2026 Watton Corey Michael Grant 30,000 $0 -1.5%
Jun 04, 2026 Shih Alvin Grant 30,000 $0 -1.5%
Jun 04, 2026 Calder Douglas W Grant 30,000 $0 -1.5%

Earnings History

Date Quarter EPS Est. EPS Actual Surprise Result
Aug 10, 2026 Q2 2026 $0.11
Aug 05, 2026 Q2 2026 $0.11
Jun 30, 2026 Q2 2026 $0.11 $0.14 +27.9% Beat
Mar 31, 2026 Q1 2026 $0.08 $0.18 +118.4% Beat
Dec 31, 2025 Q4 2025 $0.05 $0.21 +311.8% Beat
Sep 30, 2025 Q3 2025 -$0.04 -$0.01 +72.0% Beat
Jun 30, 2025 Q2 2025 $1.53 $1.21 -20.8% Miss

Track ZVRA with ThetaPal

Get insider trade alerts, AI portfolio analysis, and options roll recommendations for ZVRA and your entire portfolio.